Atlas Trials

In Vivo Alzheimer Proteomics

Clinical trial NCT02263235 · TERMINATED

Trial details

NCT number
NCT02263235
Sponsor
University Hospital, Montpellier
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Probable Alzheimer DiseaseParkinson DiseaseNeurological Disease Without Cognitive DegradationBrain TraumaAcute Hydrocephaly
Start date
2013-10-08
Primary completion
2018-05-22
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.